EN
TradingView
Upgrade Upgrade now Start free trial Upgrade plan Pay nothing extra Upgrade early Get 6 months free Use last chance Get a month for $1
Markets US Stocks Health Technology Biotechnology

Axcella Health Inc
AXLA NASDAQ

AXLA
Axcella Health Inc NASDAQ
Trade now
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Trade now
Overview
Ideas Technicals Financials Index Component

AXLA Stock Chart

Ideas

Videos only
AXLA
AXLA
, 1D
Long
AXLA: AXLA

,,, it seems to me that for AXLA this lateral phase is the preparation to try to overcome the resistance placed at 6 usd

(BY Hidden Power)
AXLA
, 15
AXLA: (BY Hidden Power)

$AXLA Axcella Health $27million Insider buys
AXLA
, 1D
Long
AXLA: $AXLA Axcella Health $27million Insider buys

$27,000,00 insider buys Nestle Health Science US Holdi 10% Owner May 18 Buy $4.75 1,936,842 $9,200,000 Epstein David R Director May 18 Buy $4.75 50,000 $237,500 Flagship Ventures Fund IV Gene 10% Owner May 18 Buy $4.75 3,800,000 $18,050,000

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Biotechnology
Axcella Health, Inc. is a biotechnology company. It engages in the research and development of treatment for diseases and improve health using endogenous metabolic modulator, or EMM, and compositions. Its product pipeline includes AXA1665, for the reduction in risk of recurrent overt hepatic encephalopathy; and AXA1125, for non-alcoholic steatohepatitis. The company was founded by Noubar B. Afeyan, Geoffrey von Maltzahn, and David A. Berry on August 27, 2008 and is headquartered in Cambridge, MA.

News

Home Stock Screener Forex Screener Crypto Screener Economic Calendar About Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter